DMK
DMK Pharmaceuticals Corporation Common Stock
Delisted
DMK was delisted on the 6th of February, 2024.
51 hedge funds and large institutions have $17.8M invested in DMK Pharmaceuticals Corporation Common Stock in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 20 increasing their positions, 3 reducing their positions, and 12 closing their positions.
Holders
51
Holders Change
-2
Holders Change %
-3.77%
% of All Funds
0.89%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
20
Reduced
3
Closed
12
Calls
$1.85M
Puts
$930K
Net Calls
+$922K
Net Calls Change
+$1.11M
Top Buyers
| 1 |
1
Balyasny Asset Management
Chicago,
Illinois
|
$1.79M |
| 2 |
GC
2
Greenlight Capital
New York
|
$1.1M |
| 3 |
3
BlackRock
New York
|
$3.02M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$6.95M |
| 5 |
5
State Street
Boston,
Massachusetts
|
$462K |
Top Sellers
| 1 |
1
Renaissance Technologies
New York
|
$0 |
| 2 |
2
Millennium Management
New York
|
$17K |
| 3 |
VF
3
Virtu Financial
New York
|
$0 |
| 4 |
4
Citadel Advisors
Miami,
Florida
|
$25K |
| 5 |
5
Group One Trading
Chicago,
Illinois
|
$0 |
